Real-time enrollment status for this uncontrolled asthma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT06572228 |
| Recruiting Status | Recruiting |
| Condition | Uncontrolled Asthma |
| Phase | Clinical Trial |
| Target Enrollment | 250 participants |
| Active Locations | 54 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | February 3, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT06572228 is currently recruiting participants. This clinical trial study for uncontrolled asthma is actively seeking new participants at 54 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06572228 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 54 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06572228 was last updated 3 weeks ago (February 3, 2026). HelloStudys verifies this status automatically.